SBC Medical Group Holdings Incorporated (SBC)
Stock analysis · NASDAQ · Industrials · Consulting Services
SBC Medical Group Holdings Incorporated (SBC) is a publicly traded company in the Industrials sector. Latest price: $5.69. Market cap $585.20M. Trailing PE 12.11. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 5 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized…
Valuation
| P/E (TTM) | 12.11× |
|---|---|
| P/S (TTM) | 3.34× |
| P/B | 2.21× |
| PEG | 0.29× |
| P/FCF (TTM) | 7.81× |
| EV / EBITDA | 5.79× |
| EV / Sales | 2.56× |
| Earnings Yield | 8.40% |
| Free Cash Flow Yield | 12.81% |
Fundamentals
| Enterprise Value | $449.12M |
|---|---|
| Revenue (TTM) | $175.17M |
| Net Income (TTM) | $49.15M |
| Free Cash Flow (TTM) | $74.76M |
| Net Debt | -$136.08M |
| Working Capital | $180.93M |
| Gross Margin | 71.27% |
| Operating Margin | 37.34% |
| Net Margin | 27.99% |
| Return on Equity | 19.31% |
| Return on Invested Capital | 12.58% |
Peers
Recent News
- SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
- SBC Medical Group (NASDAQ:SBC) Sets New 12-Month High Following Analyst Upgrade
- SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
- Analyzing UnitedHealth Group (NYSE:UNH) and SBC Medical Group (NASDAQ:SBC)
- Critical Review: 111 (NASDAQ:YI) and SBC Medical Group (NASDAQ:SBC)
Related
Browse more tickers: sitemap